tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AXSM Stock Latest News

Axsome Therapeutics price target raised to $209 from $157 at Baird
The FlyAxsome Therapeutics price target raised to $209 from $157 at Baird
3h ago
AXSM
Axsome Therapeutics price target raised to $193 from $157 at Wells Fargo
PremiumThe Fly
Axsome Therapeutics price target raised to $193 from $157 at Wells Fargo
4h ago
AXSM
Axsome Therapeutics: Strong Commercial Execution and De-Risked Pipeline Support Buy Rating and Long-Term Growth
PremiumRatings
Axsome Therapeutics: Strong Commercial Execution and De-Risked Pipeline Support Buy Rating and Long-Term Growth
14h ago
AXSM
Buy Rating on Axsome Therapeutics Backed by Strong Auvelity and Sunosi Outperformance Despite Slower Symbravo Ramp
PremiumRatings
Buy Rating on Axsome Therapeutics Backed by Strong Auvelity and Sunosi Outperformance Despite Slower Symbravo Ramp
14h ago
AXSM
Axsome Therapeutics Reports Strong Preliminary 2025 Revenue Growth
PremiumCompany Announcements
Axsome Therapeutics Reports Strong Preliminary 2025 Revenue Growth
1d ago
8K
AXSM
Axsome Therapeutics reports preliminary Q4 revenue $196M, consensus $187.02M
PremiumThe FlyAxsome Therapeutics reports preliminary Q4 revenue $196M, consensus $187.02M
1d ago
AXSM
Axsome Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Axsome Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
5d ago
AXSM
Axsome Therapeutics management to meet with B. Riley
Premium
The Fly
Axsome Therapeutics management to meet with B. Riley
7d ago
AXSM
Axsome Therapeutics price target raised to $248 from $163 at UBS
PremiumThe Fly
Axsome Therapeutics price target raised to $248 from $163 at UBS
7d ago
AXSM
Axsome Therapeutics price target raised to $225 from $169 at Needham
PremiumThe Fly
Axsome Therapeutics price target raised to $225 from $169 at Needham
8d ago
AXSM
Axsome Therapeutics price target raised to $200 from $185 at H.C. Wainwright
PremiumThe Fly
Axsome Therapeutics price target raised to $200 from $185 at H.C. Wainwright
8d ago
AXSM
Top 5 Trending Stocks by Unusual Trading Volume, 1/1/26
PremiumMarket News
Top 5 Trending Stocks by Unusual Trading Volume, 1/1/26
12d ago
FG
SNV
Axsome Therapeutics price target raised to $217 from $202 at Mizuho
PremiumThe FlyAxsome Therapeutics price target raised to $217 from $202 at Mizuho
13d ago
AXSM
Axsome Therapeutics rises 19.4%
Premium
The Fly
Axsome Therapeutics rises 19.4%
13d ago
AXSM
Axsome Therapeutics: Late-Stage CNS Pipeline and Regulatory Tailwinds Support Buy Rating
Premium
Ratings
Axsome Therapeutics: Late-Stage CNS Pipeline and Regulatory Tailwinds Support Buy Rating
13d ago
AXSM
Axsome Therapeutics rises 17.5%
PremiumThe Fly
Axsome Therapeutics rises 17.5%
13d ago
AXSM
Axsome Advances AXS-12 Toward NDA Filing for Narcolepsy
PremiumCompany Announcements
Axsome Advances AXS-12 Toward NDA Filing for Narcolepsy
13d ago
8K
AXSM
Axsome Therapeutics announces FDA acceptance, priority review of AXS-05 sNDA
PremiumThe Fly
Axsome Therapeutics announces FDA acceptance, priority review of AXS-05 sNDA
13d ago
AXSM
Axsome Therapeutics says AXS-12 NDA submission on track for January
PremiumThe Fly
Axsome Therapeutics says AXS-12 NDA submission on track for January
13d ago
AXSM
Strategic Acquisition and Pipeline Expansion Drive Buy Rating for Axsome Therapeutics
PremiumRatingsStrategic Acquisition and Pipeline Expansion Drive Buy Rating for Axsome Therapeutics
2M ago
AXSM
Avenue Therapeutics announces Baergic Bio acquisition by Axsome
Premium
The Fly
Avenue Therapeutics announces Baergic Bio acquisition by Axsome
2M ago
AZN
ATXI
Axsome enters agreement to obtain exclusive global rights to AZD7325
Premium
The Fly
Axsome enters agreement to obtain exclusive global rights to AZD7325
2M ago
AZN
ATXI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >